Hijazi, Z., Oldgren, J., Lindbäck, J., Alexander, J. H., Alings, M., De Caterina, R., . . . Wallentin, L. (2020). Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials. JAMA Netw Open.
Citação norma ChicagoHijazi, Ziad, et al. "Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials." JAMA Netw Open 2020.
MLA CitationHijazi, Ziad, et al. "Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials." JAMA Netw Open 2020.